2 Min(s) Read
By Meghna Sen Apr 26, 2023 5:39:42 PM IST (Updated)
Mankind Pharma shares are commanding a premium (GMP) of Rs 65 in the grey market on Wednesday. The shares of the company are expected to list on the leading stock exchanges BSE and NSE on May 9.
The initial public offering (IPO) of Mankind Pharma, one of the largest pharma firms in India, was subscribed 87 percent as of 5:30 pm on the second day of the issue after seeing a muted response on the first day of the sale. Bids for 2,45,19,352 shares were received against 2,80,41,192 shares on offer, according to an update shown on the NSE on Wednesday.
Recommended Articles
View All
Mann Ki Baat — here's how it became the ideal platform to discuss key healthcare issues and solutions in India
Apr 26, 2023 IST8 Min(s) Read
New dividend, bonus shares policy in Gujarat: Here is how the listed entities stack up
Apr 26, 2023 IST2 Min(s) Read
Karnataka's 4% Muslim reservation row — from history to election rhetoric
Apr 26, 2023 IST6 Min(s) Read
Healthcare in the era of AI — Illumina Asia-Pac medical head on the expanded scope of precision medicine
Apr 26, 2023 IST3 Min(s) Read
The portion for Retail Individual Investors (RIIs) got subscribed 0.25 times or 25 per cent while the category for Non-Institutional Investors (NIIs) received 1.02 times, or 102 percent subscription. The quota for Qualified Institutional Buyers (QIBs) got subscribed 1.86 times or 186 percent.
The Delhi-based pharmaceutical and healthcare products maker has set aside 35 percent of the net offer for individual investors, 50 percent for QIBs, and 15 percent for NIIs.
GMP and other details here
According to market observers, Mankind Pharma shares are commanding a premium (GMP) of Rs 65 in the grey market today, down from Rs 90 the previous day.
The initial share sale of Mankind Pharma opened for public subscription on April 26. The issue will be available for the public to bid till April 27. At Rs 4,326 crore, this will be the first biggest IPO in terms of the issue size.
The drug maker has fixed a price band of Rs 1,026-1,080 per share with a lot size of 13 equity shares with a face value of Re 1 each. At the upper end of the price band, the IPO size is estimated at Rs 4,326 crore.
The company's IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders.
Since the IPO is completely an OFS, the company will not receive any net proceeds from the issue and the entire net proceeds will go to the selling shareholders.
On day one, the IPO was subscribed 14 percent as of 5 pm, with institutional investors subscribing 0.08 times, non-institutional investors subscribing 33 percent, and retail investor portion saw a 10 percent subscription.
Kotak Mahindra Capital Company, Axis Capital, IIFL Securities, Jefferies India and JP Morgan India are the book-running lead managers to the issue.
The shares of the company are expected to list on the leading stock exchanges BSE and NSE on May 9, 2023.
First Published: Apr 26, 2023 1:07 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
